stachydrine has been researched along with Hypertrophy, Left Ventricular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Guo, W; Hu, P; Lu, R; Shan, X; Tian, J; Wang, S; Wu, Q; Xu, M; Zhang, C; Zhao, P; Zheng, J | 1 |
1 other study(ies) available for stachydrine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
Topics: Animals; Calcineurin; Cells, Cultured; Disease Models, Animal; Gene Expression Regulation; Hypertrophy, Left Ventricular; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Proline; Rats, Wistar; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2020 |